Launch week offerEnds in00h00m00s

Florence Boissière-Michot

Institut de Recherche en Cancérologie de Montpellier
Country flagFrance

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (12)

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2023

There exists a variety of studies about tumor-infiltrating immune cells (TIICs) in cervical cancer, but their prognostic value in correlation with the histopathological subtype has never been investigated. Therefore, the aim of this study was to quantify TIICs in a panel of 238 sporadic cervical cancers and investigate the correlation with cervical cancer subtype and patient survival. TIICs levels were significantly increased in the subgroup of CSCC (191 samples) in comparison to CAC (47 samples). In CSCC, TIICs’ infiltration showed a negative correlation with age, FIGO stage and with the histone protein modification H3K4me3. Moreover, in CAC, it was positively correlated with p16 and with the glucocorticoid receptor and inversely correlated with the MDM2 protein and with H3K4me3. Interestingly, immune infiltration was an independent positive prognosticator for disease-free survival (DFS) in patients with CSCC, those bearing tumors with the strongest TIICs infiltration showing the better DFS. Altogether, the present study provides a differentiated overview of the relations between TIIC levels and prognosis in patients with CSCC vs. patients with CAC.

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (8)

Angélique Bobrie

Institut de Recherche en Cancérologie de Montpellier

FRANCE
View details

Andrei Turtoi

Lab Head

Institut de Recherche en Cancérologie de Montpellier

FRANCE
View details

LAURENT-MATHA Valérie

assistant professor

Institut de Recherche en Cancérologie de Montpellier

FRANCE
View details

Priyanka Sharma

Team Leader

Institute of Pharmacology and Structural Biology

FRANCE
View details

Vincent Cavaillès

University of Montpellier

FRANCE
View details

Carl Mathis Wild

University Hospital Augsburg

GERMANY
View details

aude mallavialle

Institut de Recherche en Cancérologie de Montpellier

FRANCE
View details

evelyne Crapez

Head of translational Research Unit (MD, PhD)

Institut de Recherche en Cancérologie de Montpellier

FRANCE
View details